CJC-1295 / GHRP-2 Blend
This blend pairs CJC-1295 with GHRP-2, positioned as a middle ground between the CJC-1295/ipamorelin pairing (more selective, milder) and CJC-1295/GHRP-6 pairing (stronger appetite stimulation). GHRP-2 is a more potent secretagogue than ipamorelin at the ghrelin receptor while producing less appetite stimulation than GHRP-6. Both components have an extensive individual research history in growth-hormone secretagogue literature, though the fixed combination has not been studied as its own entity. It is discussed in the context of sustained GH elevation for recovery and body-composition-focused research. It is not approved for human medical use.
Reported benefits
- Sustains elevated growth-hormone levels
- Supports recovery
- Associated with lean mass support in research contexts
- Moderate appetite effect compared with GHRP-6 pairings
How it works
CJC-1295 sustains elevated GHRH-receptor stimulation, particularly in its DAC-extended form, supporting a longer window of GH release. GHRP-2 provides a potent ghrelin-receptor-driven GH pulse with a moderate side-effect profile relative to other GHRPs. Combined, the two are described as producing strong, sustained GH release across the dosing window.
Dosing ranges
| Tier | Dose | Frequency |
|---|---|---|
| Low | 200 mcg | once daily (DAC) or twice daily (non-DAC) |
| Moderate | 300 mcg | once daily (DAC) or twice daily (non-DAC) |
| High | 500 mcg | twice daily |
Estimate your dose
Dose estimator
Educational estimate for CJC-1295 / GHRP-2 Blend, scaled to body size. Not medical advice.
Read before using
This tool produces a rough, educational estimate by scaling commonly-published research ranges to lean body mass. It is not a prescription, medical advice, or a substitute for a licensed clinician. Most peptides use fixed dosing, not weight-based dosing. Individual needs vary. You are solely responsible for how you use this information.
Mixing & syringe units
Target dose follows the estimate above. Change it there, or edit it directly below.
Reconstitution calculator
How much water to add and how many insulin-syringe units to draw for CJC-1295 / GHRP-2 Blend. Educational only.
Draw to this mark
6units
= 0.06 mL for a 300 mcg dose
Concentration
5,000 mcg/mL
Doses per vial
33
A U-100 syringe reads 100 units per mL. This is a reconstitution math helper only, not a prescription or dosing advice. Verify every calculation and consult a qualified healthcare provider.
Possible side effects
Stacking notes
Positioned as an alternative to CJC-1295/ipamorelin for researchers interested in a more potent secretagogue, at the cost of a somewhat less selective side-effect profile.
Common protocols
Common questions
What is CJC-1295 / GHRP-2 Blend used for?
This blend pairs CJC-1295 with GHRP-2, positioned as a middle ground between the CJC-1295/ipamorelin pairing (more selective, milder) and CJC-1295/GHRP-6 pairing (stronger appetite stimulation). GHRP-2 is a more potent secretagogue than ipamorelin at the ghrelin receptor while producing less appetite stimulation than GHRP-6. Both components have an extensive individual research history in growth-hormone secretagogue literature, though the fixed combination has not been studied as its own entity. It is discussed in the context of sustained GH elevation for recovery and body-composition-focused research. It is not approved for human medical use. Reported benefits include sustains elevated growth-hormone levels, supports recovery, associated with lean mass support in research contexts.
What is a typical CJC-1295 / GHRP-2 Blend dose?
Reported ranges run 200-500 mcg. A low protocol is 200 mcg once daily (dac) or twice daily (non-dac), and a high protocol is 500 mcg twice daily. This is reference information, not a dosing recommendation.
What is the half life of CJC-1295 / GHRP-2 Blend?
CJC-1295 without DAC is reported at roughly 30 minutes (or several days with DAC); GHRP-2 is reported at roughly 30-60 minutes.. That is what sets the dosing frequency, and it is why the timing guidance is ~30 min before bed, empty stomach.
How is CJC-1295 / GHRP-2 Blend administered?
Subcutaneous: into fat, under the skin. Injected subcutaneously into the abdomen; dosing frequency depends on whether the non-DAC or DAC form of CJC-1295 is used.
How long is a CJC-1295 / GHRP-2 Blend cycle?
8-12 weeks on, followed by 4 weeks off. Cycling recommendations mirror those for other CJC-1295-based pairings, aimed at reducing theoretical pituitary downregulation.
What are the side effects of CJC-1295 / GHRP-2 Blend?
Reported side effects include water retention, injection site irritation, mild appetite increase, headache, flushing. Evidence level for this compound is well studied.
Partner offer · $20 off
When did you last
check your blood work?
Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.
- 1Order your kitTakes two minutes online, $20 off with this link.
- 2Collect at homePainless draw with free home pickup, no lab visit.
- 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Partner offer · opens rythm.health
Educational use only, not medical advice. This profile is provided for research and educational purposes. CJC-1295 / GHRP-2 Blend may be a research compound or a prescription medication; nothing here is intended to diagnose, treat, cure, or prevent any disease. Dosing figures reflect commonly-published research ranges, not a prescription. Consult a qualified healthcare provider before making any health decision. Read the full disclaimer →